FDA Inspection
Vimta Labs LimitedVimta Labs Limited – FDA Inspection, Sep 3, 2026
Record Details
This FDA Inspection record concerns Vimta Labs Limited, with an inspection on September 3, 2026, issued by the Office of Inspections and Investigations, covering human drugs.
View Company Profile
ID · 21a663c5-fe21-4aa7-a525-35170a12f054
Inspection Facts
- Inspection number
- 1340030
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
1- 21 CFR 211.22(d)Procedures not in writing, fully followed
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Vimta Labs Limited
7| Date | Classification | Office | Project area |
|---|---|---|---|
| November 7, 2025 | Not classified | Office of Inspections and Investigations | |
| March 17, 2023 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 13, 2019 | Not classified | Office of Inspections and Investigations | |
| October 26, 2018 | Not classified | Office of Inspections and Investigations | |
| April 27, 2018 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Vimta Labs Limited
- FDA Inspection 1294544 - 2025-11-07
- FDA Inspection 1203719 - 2023-03-17
- FDA Inspection 1090966 - 2019-05-13
- FDA Inspection 1070108 - 2018-10-26
- FDA Inspection 1056558 - 2018-04-27
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.